Client News

Rezolve Ai (Nasdaq: RZLV) to Present at Sidoti Micro-Cap Investor Conference January 22-23, 2025

NEW YORK, Jan. 16, 2025 (GLOBE NEWSWIRE) — Rezolve Ai (Nasdaq: RZLV), a global leader in AI-driven retail and commerce solutions today announces that Daniel M. Wagner, Founder, Chairman, and CEO, will present and host one-on-one meetings with investors at the Sidoti Micro-Cap Virtual Conference, taking place on January 22-23, 2025. Conference details: Presentation:  Wednesday, January […]

Hardware Integrity is Critical to AI’s Foundation – Here’s How SMX (NASDAQ:SMX) Can Ensure It

MIAMI, FL / ACCESS Newswire / January 16, 2025 / Artificial intelligence (AI) is no longer just a concept; it’s a transformative force reshaping industries. That’s not surprising. AI platforms can process in nanoseconds what once took days, weeks, or even years to evaluate. This capability is accelerating advancements in biotech, mathematics, sports science, and virtually every sector […]

Greenlane (NASDAQ:GNLN) Regains Full Compliance with Nasdaq Continued Listing Rules

Appointment of new independent director, Michael Howe, brings significant expertise in commercial strategy, operations and business development BOCA RATON, FL / ACCESSWIRE / January 15, 2025 / Greenlane Holdings, Inc. (“Greenlane” or the “Company”) (NASDAQ:GNLN), one of the premier global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today announced it has […]

Rezolve Ai (NASDAQ: RZLV) CEO Daniel Wagner Applauds National Data Library Announcement but Urges Government to Prioritize UK AI Companies

LONDON, Jan. 13, 2025 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV) founder and CEO Daniel Wagner today commended the UK government’s recent decision to create a National Data Library to help give developers access to high quality data as part of a plan to fuel AI progress and high-quality AI applications, calling it a transformative […]

NanoViricides (NYSE American:NNVC) to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025

SHELTON, CT / ACCESSWIRE / January 13, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced today that it is presenting at Biotech Showcase™ 2025 in San Fransisco, being held in parallel to the JP Morgan Life Sciences Conference. Event Information: Event […]

SMX (NASDAQ:SMX) Announces Effective Date of Reverse Stock Split

NEW YORK, NY / ACCESSWIRE / January 13, 2025 / SMX (Security Matters) Public Limited Company (NASDAQ:SMX)(NASDAQ:SMXWW) (the “Company”), today announced that the reverse stock split of the Company’s ordinary shares, which was previously approved by the Company’s shareholders on December 10, 2024, will begin trading on an adjusted basis giving effect to the reverse stock […]

Rezolve Ai (NASDAQ: RZLV) Poised for Global Growth as it enters 2025 with Strong Customer Acquisitions, Strategic Partnerships, and Groundbreaking Innovations

AI and Global Expansion Lead Rezolve Ai’s Transformative Journey into the Future of Retail NEW YORK, Jan. 13, 2025 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV) is entering 2025 with momentum, announcing customer acquisitions across diverse geographies, a robust pipeline of prospects, and the launch of transformative solutions designed to drive the future of retail. […]

Amesite (Nasdaq: AMST) Announces Closing of Public Offering

DETROIT, Jan. 08, 2025 (GLOBE NEWSWIRE) — Amesite Inc. (Nasdaq: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced the closing of its “best efforts” underwritten public offering of 1,201,667 shares of its common stock at a public offering price of $3.00 per share, before underwriting […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.